Tamilnad Mercantile Bank Ltd (TMB) Q1 FY27 Results Analysis: Cost-to-Income Improves 1005 bps, NII Surges 32%

CompoundingAI Research Updated July 27, 2026 2 min read
Positive

Tamilnad Mercantile Bank Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,900.79 Cr (+17.50% YoY) and PAT growth of +34.97% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 27, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,900.79 Cr (+17.50% YoY)
PAT (Q1)Rs. 411.51 Cr (+34.97% YoY)
EPS (Q1)Rs. 25.99 (+35.00% YoY)
Market capRs. 13,076.66 Cr
CMPRs. 825.80

Quarter Snapshot

TMB delivered a strong Q1 with 27.5% loan growth, 32% NII growth, and a 1,005 bps improvement in cost-to-income ratio to 39.1%. Asset quality continued to improve with GNPA at 0.69% and NNPA at 0.17%. The key watch item is the rising credit-deposit ratio (88.56%) and increased borrowings, which could pressure margins if deposit growth does not accelerate.

Key Investment Insights

Key Positives

  • Advances grew 27.5% YoY, well above industry growth of ~15.8%.
  • NII grew 32.0% YoY, driving NIM proxy expansion of 421 bps.
  • Cost-to-income ratio improved 1,005 bps YoY to 39.10%.
  • GNPA improved to 0.69% from 1.22% YoY; NNPA to 0.17% from 0.33%.
  • PAT grew 35.0% YoY to Rs.411.51 Cr.
  • PPOP grew 48.2% YoY.
  • Operating expenses declined 1.5% YoY despite revenue growth of 17.5%.
  • Capital adequacy ratio of 32.33% with CET1 at 31.30%.

Risk Factors

  • Credit-deposit ratio rose to 88.56% from 83.14% a year ago, indicating funding gap.
  • Borrowings jumped 187.7% YoY to Rs.1,540.21 Cr to fund loan growth.
  • Treasury segment revenue declined 10.3% YoY, segment result fell 40.9%.
  • Provisions increased significantly YoY (+546.6%) and QoQ (+187.0%), though partly due to loan growth.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now